Boron-lipiodol: A potential new drug for the treatment of liver tumors

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 台中附設醫院 > 期刊論文 > Item 310903500/29284

請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29284

題名:	Boron-lipiodol: A potential new drug for the treatment of liver tumors
作者:	Lin, WY;Chi, CW;Ho, YJ;Wu, IC;Chung, YT;Chen, SD;Chou, FI;Kai, JJ;Lui, WY;Chen, TJ;Lin, YC
貢獻者:	附設醫院放射線部;Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan;Natl Chung Hsing Univ, Inst Vet Pathol, Taichung 40227, Taiwan;Taichung Vet Gen Hosp, Dept Nucl Med, Taichung 40705, Taiwan;Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan;Taipei Vet Gen Hosp, Dept Surg, Taipei 11217, Taiwan;Natl Yang Ming Univ, Taipei 11217, Taiwan;China Med Coll Hosp, Dept Radiol, Taichung 40402, Taiwan;Jen Ai Gen Hosp, Taichung, Taiwan;Natl Tsing Hua Univ, Nucl Sci & Technol Dev Ctr, Isotope Div, Hsinchu 30013, Taiwan;Natl Tsing Hua Univ, Dept Engineer & Syst Sci, Hsinchu 30013, Taiwan;Inst Nucl Energy Res, Lung Tan, Taiwan
日期:	2002
上傳時間:	2010-09-24 14:30:55 (UTC+8)
出版者:	INT INST ANTICANCER RESEARCH
摘要:	The purpose of this study was to prepare and evaluate the feasibility and biocompatibility of a new composite as a bone substitute. The new composite (GTGC) was mainly composed of tricalcium phosphate ceramics and gelatin to which Chi-Li-Saan, a Chinese medicinal remedy was added. The GTGC composite was manually packed into cylindrical Teflon molds, dried overnight in an oven and sterilized by gamma-ray prior to use. Mature New Zealand rabbits, weighting 3-3.5 kg, underwent full-thickness excision of the parietal bone. In the experimental group, bone defects of 12 animals were filled with the GTGC composites and another 12 unreconstructed rabbits were considered as controls. Three rabbits were examined for each group in every time period at 2, 4, 8 and 12 weeks after operation. There was no evidence of adverse tissue reaction to the GTGC composite. In addition, examination with light and fluorescent microscopy revealed a significantly greater amount of new bone ingrowth in the GTGC group at the same implantion time as compared with the controls. Therefore, the GTGC composite could serve as a useful substitute when repairing bone defects.
關聯:	ANTICANCER RESEARCH 22(6C):3989-3992
顯示於類別:	[台中附設醫院] 期刊論文

文件中的檔案:

沒有與此文件相關的檔案.

在CMUR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....